High materiality7/10
Design Therapeutics initiated with an Overweight at Wells Fargo
Why it may matterVerify against the original reporting
Overweight initiation supports bullish view.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo initiates DSGN with Overweight; target $26 vs current price $12.24; priceChangeSinceSignal +0.82.
- Wells Fargo initiates DSGN with Overweight
- Target $26 vs current $12.24
- Price change since signal +0.82
Key facts
- 01
Target: $26
- 02
Posted price: $12.24
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.